| Hydroxyethylstarch |
20120381/ 02.08.2012 |
Voluven 10%, Solution for infusion, 500, ml, Pack: 10 |
Фрезениус Каби България ЕООД, България |
Fresenius Kabi Deutscland GmbH, 61346 Bad Homburg v.d.H., Германия |
194.51 |
38.9 |
233.41 |
4% |
7.78 |
202.29 |
40.46 |
242.75 |
16% |
25 |
227.29 |
45.46 |
272.75 |
|
КЦРР-2748/20.03.2013 |
19.04.2013 |
19.04.2013 |
Неактивен |
1771 |
| Hydroxyethylstarch |
ІІ-1342/28.12.2007 г. |
Voluven 6%, Solution for infusion, 500 ml, -, Pack: 1 bottle |
Fresenius Kabi Deutschland GmbH, Германия |
Fresenius Kabi Deutschland GmbH, D-61346 Bad Homburg v.d.H., Germany Fresenius Kabi France, 6 rue du Rempart, B.P. 611, 27400 Louviers Cedex, France / Fresenius Kabi Polska Sp. Z.o.o., Wytwornia Plynow Infuzyjnych, 25 Sienkiewicza Street, 99-300 Kutno, Poland |
12.22 |
2.44 |
14.66 |
6% |
0.73 |
12.95 |
2.59 |
15.54 |
18% |
2.2 |
15.15 |
3.03 |
18.18 |
|
НСР-7205/09.10.2015. |
24.10.2015 |
24.10.2015 |
Активен |
792 |
| Voriconazole |
EU/1/13/835/002 |
Voriconazole, Film coated tablet, 50, mg, Pack: 10 |
Accord Healthcare Limited, Обединено Кралство |
Accord Healthcare Limited, Обединено кралство |
150.19 |
30.04 |
180.23 |
4% |
6.01 |
156.2 |
31.24 |
187.44 |
16% |
24.03 |
180.23 |
36.05 |
216.28 |
|
НСР-4561/03.09.2014 |
16.12.2014 |
16.12.2014 |
Активен |
3385 |
| Voriconazole |
EU/1/13/835/002 |
Voriconazole, Film coated tablet, 50, mg, Pack: 10 |
Accord Healthcare Limited, Обединено Кралство |
Accord Healthcare Limited, Обединено кралство |
150.19 |
30.04 |
180.23 |
4% |
6.01 |
156.2 |
31.24 |
187.44 |
16% |
24.03 |
180.23 |
36.05 |
216.28 |
|
НСР-4561/03.09.2014 |
16.12.2014 |
16.12.2014 |
Неактивен |
3385 |
| Voriconazole |
EU/1/13/835/011 |
Voriconazole, Film coated tablet, 200, mg, Pack: 10 |
Accord Healthcare Limited, Обединено Кралство |
Accord Healthcare Limited, Обединено кралство |
600.01 |
120 |
720.01 |
4% |
10 |
610.01 |
122 |
732.01 |
16% |
25 |
635.01 |
127 |
762.01 |
|
НСР-4561/03.09.2014 |
16.12.2014 |
16.12.2014 |
Активен |
3384 |
| Voriconazole |
EU/1/13/835/011 |
Voriconazole, Film coated tablet, 200, mg, Pack: 10 |
Accord Healthcare Limited, Обединено Кралство |
Accord Healthcare Limited, Обединено кралство |
600.01 |
120 |
720.01 |
4% |
10 |
610.01 |
122 |
732.01 |
16% |
25 |
635.01 |
127 |
762.01 |
|
НСР-4561/03.09.2014 |
16.12.2014 |
16.12.2014 |
Неактивен |
3384 |
| Voriconazole |
20160171 |
Voriconazole Actavis, Powder for solution for infusion, 200, mg, Pack: 1 |
Actavis Group PTC ehf., Исландия |
S.C. Sindan Pharma SRL, Румъния; Actavis Italy S.p.a., Nerviano Plant, Италия |
145.12 |
29.02 |
174.14 |
4% |
5.8 |
150.92 |
30.18 |
181.1 |
16% |
23.22 |
174.14 |
34.83 |
208.97 |
|
НСР-9976/16.08.2016 |
02.09.2016 |
02.09.2016 |
Активен |
15145 |
| Voriconazole |
20140124 |
Voriconazole Sandoz, Powder for solution for infusion, 200, mg, Pack: 1 |
Sandoz d.d., Словения |
Lek Pharmaceuticals d.d., Словения; Salutas Pharma GmbH, Германия |
145.12 |
29.02 |
174.14 |
4% |
5.8 |
150.92 |
30.18 |
181.1 |
16% |
23.22 |
174.14 |
34.83 |
208.97 |
|
НСР-5759/26.02.2015. |
12.03.2015 |
12.03.2015 |
Активен |
3622 |
| Voriconazole |
20140124 |
Voriconazole Sandoz, Powder for solution for infusion, 200, mg, Pack: 1 |
Sandoz d.d., Словения |
Lek Pharmaceuticals d.d., Словения; Salutas Pharma GmbH, Германия |
145.12 |
29.02 |
174.14 |
4% |
5.8 |
150.92 |
30.18 |
181.1 |
16% |
23.22 |
174.14 |
34.83 |
208.97 |
|
НСР-5759/26.02.2015. |
12.03.2015 |
12.03.2015 |
Неактивен |
3622 |
| Voriconazole |
20150271 |
Vorifungal, Powder for solution for infusion, 200, mg, Pack: 1 |
Чайкафарма Висококачествените лекарства АД, България |
Чайкафарма Висококачествените Лекарства АД, София, България |
145.14 |
29.03 |
174.17 |
4% |
5.81 |
150.95 |
30.19 |
181.14 |
16% |
23.22 |
174.17 |
34.83 |
209 |
|
HCР-7117/24.09.2015 |
10.10.2015 |
10.10.2015 |
Активен |
4080 |
| Voriconazole |
20150271 |
Vorifungal, Powder for solution for infusion, 200, mg, Pack: 1 |
Чайкафарма Висококачествените лекарства АД, България |
Чайкафарма Висококачествените Лекарства АД, София, България |
145.14 |
29.03 |
174.17 |
4% |
5.81 |
150.95 |
30.19 |
181.14 |
16% |
23.22 |
174.17 |
34.83 |
209 |
|
HCР-7117/24.09.2015 |
10.10.2015 |
10.10.2015 |
Неактивен |
4080 |
| Bortezomib |
20150191 |
Vortemyel, Powder for solution for injection, 3.5, mg, Pack: 1 |
Alvogen IPCo S.àr.l, Люксембург |
Synthon Hispania SL, C/ Castelló № 1, Pol. Las Salinas, Sant Boi de Llobregat, 08830, Barcelona, Испания; Synthon s.r.o., Brnenska 32/c.p.597, Blansko, 678 01, Чехия |
832.24 |
166.45 |
998.69 |
4% |
10 |
842.24 |
168.45 |
1010.69 |
16% |
25 |
867.24 |
173.45 |
1040.69 |
|
НСР-6576/29.06.2015.; НСР-10334/15.09.2016 |
02.11.2016 |
02.11.2016 |
Активен |
4014 |
| Bortezomib |
20150191 |
Vortemyel, Powder for solution for injection, 3.5, mg, Pack: 1 |
Alvogen IPCo S.àr.l, Люксембург |
Synthon Hispania SL, C/ Castelló № 1, Pol. Las Salinas, Sant Boi de Llobregat, 08830, Barcelona, Испания; Synthon s.r.o., Brnenska 32/c.p.597, Blansko, 678 01, Чехия |
1385.04 |
277.01 |
1662.05 |
4% |
10 |
1395.04 |
279.01 |
1674.05 |
16% |
25 |
1420.04 |
284.01 |
1704.05 |
|
НСР-6576/29.06.2015. |
29.06.2015 |
29.06.2015 |
Неактивен |
4014 |
| Rosuvastatin |
II-10741/ 13.09.2010 |
Vosustat, Film coated tablet, 10, mg, Pack: 28 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
Adamed Sp. z o.o., Pieńków 149, 05-152 Czosnów, Полша |
5.34 |
1.07 |
6.41 |
7% |
0.37 |
5.71 |
1.14 |
6.85 |
20% |
1.07 |
6.78 |
1.36 |
8.14 |
|
НСР-7526/19.11.2015. |
05.12.2015 |
05.12.2015 |
Активен |
3090 |
| Rosuvastatin |
II-10741/ 13.09.2010 |
Vosustat, Film coated tablet, 10, mg, Pack: 28 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
Adamed Sp. z o.o., Pieńków 149, 05-152 Czosnów, Полша |
6.67 |
1.33 |
8 |
7% |
0.47 |
7.14 |
1.43 |
8.57 |
20% |
1.33 |
8.47 |
1.69 |
10.16 |
|
НСР-4250/30.07.2014 |
26.08.2014 |
26.08.2014 |
Неактивен |
3090 |
| Rosuvastatin |
II-10742/ 13.09.2010 |
Vosustat, Film coated tablet, 20, mg, Pack: 28 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
Pharma Swiss Ceska republiкa s.r.o. |
15.84 |
3.17 |
19.01 |
6% |
0.95 |
16.79 |
3.36 |
20.15 |
18% |
2.85 |
19.64 |
3.93 |
23.57 |
Цената се заличава с решение НСР-1995/06.12.2013 |
НСР-1508/25.10.2013 |
14.11.2013 |
14.11.2013 |
Заличен |
2220 |
| Rosuvastatin |
II-10741/ 13.09.2010 |
Vosustat, Film coated tablet, 10, mg, Pack: 28 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
Adamed Sp. z o.o., Pieńków 149, 05-152 Czosnów, Полша |
9.37 |
1.87 |
11.24 |
7% |
0.66 |
10.03 |
2.01 |
12.04 |
20% |
1.87 |
11.9 |
2.38 |
14.28 |
корекц. НСР-4121/10.07.2014 |
НСР-1508/25.10.2013 |
14.11.2013 |
14.11.2013 |
Неактивен |
3090 |
| Rosuvastatin |
II-10742/ 13.09.2010 |
Vosustat, Film coated tablet, 20, mg, Pack: 28 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
Adamed Sp.z.o.o.,Pienkow 149, 05-152 Czosnow, Полша |
25.07 |
5.01 |
30.08 |
6% |
1.5 |
26.57 |
5.31 |
31.88 |
18% |
4.51 |
31.08 |
6.22 |
37.3 |
промяна на обстоятелства решение КЦPP-2709/20.03.2013 |
КЦРР-688/30.05.2012 |
18.06.2012 |
18.06.2012 |
Неактивен |
2220 |
| Rosuvastatin |
II-10741/ 13.09.2010 |
Vosustat, Film coated tablet, 10, mg, Pack: 28 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
Adamed Sp.z.o.o.,Pienkow 149, 05-152 Czosnow, Полша |
13.08 |
2.62 |
15.7 |
6% |
0.78 |
13.86 |
2.77 |
16.63 |
18% |
2.35 |
16.21 |
3.24 |
19.45 |
промяна на обстоятелства решение КЦPP-2709/20.03.2013 |
КЦРР-688/30.05.2012 |
18.06.2012 |
18.06.2012 |
Неактивен |
3090 |
| Rosuvastatin |
№ ІІ - 10743/13.09.2010 |
Vosustat, Film coated tablet, 40, mg, Pack: 28 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
Adamed Sp,z.o.o Полша |
52.81 |
10.56 |
63.37 |
4% |
2.11 |
54.92 |
10.98 |
65.9 |
16% |
8.45 |
63.37 |
12.67 |
76.04 |
промяна на обстоятелства решение КЦPP-2709/20.03.2013; Цената се заличава с решение НСР-1995/06.12.2013 |
КЦ-2020/24.02.2011 |
11.03.2011 |
11.03.2011 |
Заличен |
1029 |
| Rosuvastatin |
II-10742/13.09.2010 |
Vosustat, Film coated tablet, 20, mg, Pack: 28 |
Galex d.d., Словения |
Adamed Sp.z.o.o.,Pienkow 149, 05-152 Czosnow, Полша |
33.25 |
6.65 |
39.9 |
6% |
2 |
35.25 |
7.05 |
42.3 |
18% |
5.99 |
41.24 |
8.25 |
49.49 |
|
КЦ-2006/15.02.2011 |
02.03.2011 |
02.03.2011 |
Неактивен |
2220 |
| Rosuvastatin |
II-10741/13.09.2010 |
Vosustat, Film coated tablet, 10, mg, Pack: 28 |
Galex d.d., Словения |
Adamed Sp.z.o.o.,Pienkow 149, 05-152 Czosnow, Полша |
18.87 |
3.77 |
22.64 |
8% |
1.51 |
20.38 |
4.08 |
24.46 |
20% |
3.77 |
24.15 |
4.83 |
28.98 |
|
КЦ-2006/15.02.2011 |
02.03.2011 |
02.03.2011 |
Неактивен |
3090 |
| Pazopanib |
EU/1/10/628/004 |
VOTRIENT, Film coated tablet, 400, mg, Pack: 60 |
Novartis Europharm Limited, Обединено Кралство |
Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations) Priory Street Ware Herfordshire SG12 ODJ United kingdom; Glaxo Wellcome SA. Avda. Extremadura, 309400 Aranda De Duero, Burgos Spain |
4502.14 |
900.43 |
5402.57 |
4% |
10 |
4512.14 |
902.43 |
5414.57 |
16% |
25 |
4537.14 |
907.43 |
5444.57 |
Отхвърлена жалба от Комисия по прозрачност с решение КП-76/06.03.2015; промяна в обстоятелствата НСР-6988/24.08.2015 |
НСР-5200/04.12.2014; НСР-9614/23.06.2016 |
02.08.2016 |
02.08.2016 |
Активен |
3669 |
| Pazopanib |
EU/1/10/628/004 |
VOTRIENT, Film coated tablet, 400, mg, Pack: 60 |
Novartis Europharm Limited, Обединено Кралство |
Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations) Priory Street Ware Herfordshire SG12 ODJ United kingdom; Glaxo Wellcome SA. Avda. Extremadura, 309400 Aranda De Duero, Burgos Spain |
4531.97 |
906.39 |
5438.36 |
4% |
10 |
4541.97 |
908.39 |
5450.36 |
16% |
25 |
4566.97 |
913.39 |
5480.36 |
Отхвърлена жалба от Комисия по прозрачност с решение КП-76/06.03.2015; промяна в обстоятелствата НСР-6988/24.08.2015 |
НСР-5200/04.12.2014 |
02.04.2015 |
02.04.2015 |
Неактивен |
3669 |
| Pazopanib |
EU/1/10/628/004 |
VOTRIENT, Film coated tablet, 400, mg, Pack: 60 |
Glaxo Group Ltd., Обединено Кралство |
Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations) Priory Street Ware Herfordshire SG12 ODJ United kingdom Glaxo Wellcome SA. Avda. Extremadura, 309400 Aranda De Duero, Burgos Spain |
5045.18 |
1009.04 |
6054.22 |
4% |
10 |
5055.18 |
1011.04 |
6066.22 |
16% |
25 |
5080.18 |
1016.04 |
6096.22 |
|
НСР-3113/26.03.2014 |
10.04.2014 |
10.04.2014 |
Неактивен |
3669 |